CroíValve raises €8m to study DUO coaptation valve system
The company intends to use the funding to support a European feasibility study of its CroíValve Transcatheter Tricuspid…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
08 Feb 22
The company intends to use the funding to support a European feasibility study of its CroíValve Transcatheter Tricuspid…
07 Feb 22
The acquisition includes J-Valve, developed by JC Medical, is a minimally invasive transcatheter aortic valve replacement (TAVR) device…
03 Feb 22
Under the terms of the agreement LIVMOR will develop a HeartBeam branded version, the HeartBeam Platform, of the…
02 Feb 22
PROCYSS is a randomised controlled trial (RCT) that evaluates CytoSorb to restore hemodynamic stability in patients with refractory…
28 Jan 22
Apart from leading the funding round, Grand Pharma has secured an exclusive licence from InnovHeart to develop and…
28 Jan 22
MateraCor’s Trans-Catheter Myocardial Restoration (TCMR) device includes an implantable hydrogel and a minimally invasive endocardial delivery system to…
28 Jan 22
Philips expands remote cardiac monitoring portfolio with patch-based, clinical-grade ECG designed to improve patient recruitment, compliance and retention…
28 Jan 22
WellSky’s technology platform and provider networks will coordinate the execution of in-home, heart failure protocols to lower hospital…
27 Jan 22
AccurKardia is a digital-first and software-only healthcare company focused on a combination of smart devices, reliable and actionable…
20 Jan 22
JenaValve Technology develops and manufactures transcatheter aortic valve replacement (TAVR) systems to treat patients suffering from aortic valve…